ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19

INTRODUCTION: COVID-19, caused by SARS-CoV-2, remains a global pandemic that has affected more than 100 million people worldwide with over 4.8 million deaths as of October 2021. Patients with diabetes have both an increased susceptibility to SARS-CoV-2 infection, enhanced disease severity and increa...

Descripción completa

Detalles Bibliográficos
Autores principales: McCafferty, Kieran, Hollowood, Zoe, Allan, Michelle, Lockhart, Donna, Chorlton, Jamie, Martin, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637313/
https://www.ncbi.nlm.nih.gov/pubmed/34853102
http://dx.doi.org/10.1136/bmjopen-2021-049650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637313/
https://www.ncbi.nlm.nih.gov/pubmed/34853102
http://dx.doi.org/10.1136/bmjopen-2021-049650

Ejemplares similares